Healthcare  Name:  Sector: Principia Healthcare  Summary: Development stage company that was formed to develop and commercialize therapeutically enhanced proprietary biopharmaceuticals offering significant reductions in dosage, injection frequency, side effects, and overall cost of treatment.  Stage of Initial  Investment: Seed/Early  Liquidity: Acquired by Human Genome Sciences (Nasdaq: HGSI)
	Copyright ©2009 Rho Capital Partners, Inc.